Rob Winder
robwinder.bsky.social
Rob Winder
@robwinder.bsky.social
370 followers 340 following 49 posts
Life science and healthcare business communicator Early talent recruitment coordinator for strategic communications at FTI Consulting in London. The views expressed are my own, and should not be considered to be the views of my employer.
Posts Media Videos Starter Packs
During the last election, I think the industry spent so much time distracted by the IRA and its potential impact on drug pricing that it missed the threats to the FDA and to scientific research and the potential imposition of tarrifs.
This is not good for the sector or for the health of patients.

While the issue in the UK is, yet another, government that really does not understand the connection between investment and uptake of medicines, I feel the issue in the US may be self-inflicted.
This is not good at all.

If the UK government really wants to support the life sciences it needs to encourage investment here, not discourage it.

There have been at least seven government strategies for life sciences this century, it is time a government actually put one into action.
And none of those in between are duds.
This is not a "UK problem". The global biopharma industry has been built on M&A.

If a company can be acquired for £46bn, as was the case with Shire, then any company can.

What is important is that investors in companies being acquired make a sufficient return to want to invest in biotech again.
However, one area that I think will be impossible is to "build bigger, better British biotechs and keep them here, rather than them being sold to multinationals".
Kate Bingham's thoughts on the UK government's life sciences strategy are worth reading.

The uptake of innovative products is essential if the Office for Life Sciences really wants to be successful in surpassing its goals.
The UK needs to pick up the pace on life sciences
Focusing relentlessly on low drug costs is the wrong approach
www.ft.com
Make that 40. First max score on Pointed.
It's always nice to see good news when you wake up. Congrats to the #moversandshakers team.

A debate is only the first step, genuine action needs to be taken to help people get access to neurologists to enable early diagnosis.
open.substack.com/pub/rorycell... We did it! The #moversandshakers Parky petition hit the 100,000 target which triggers a parliamentary debate. But we’re not finished - the struggle continues!
We* did it! Parky Petition hits 100K
*That includes you if you signed or helped out..
open.substack.com
I'm not surprised that the trade associations are not particularly positive in their responses to this report.

There have been several similar ones since the turn of the century and successive govenments have always promised a lot and delivered only a fraction.

I hope it is different this time.
The overarching ambition of the Life Sciences Sector Plan is admirable.

However, I feel it is lacking detail.

Additionally, there is a need to couple developing an innovative industry with the uptake of innovative products in the NHS. That appears to be missing.
Life Sciences Sector Plan
The Life Sciences Sector Plan sets out a vision and an action plan to drive growth, innovation, and better health outcomes.
www.gov.uk
On the AI theme, @parmy.bsky.social's "Supremacy"
I would agree on the prose. However, I think the recent iterations of some of the GPT systems have significantly improved prose compared with the output a few months ago, which will make recruitment for roles that require writing more difficult.
How do you separate the genuine writers from the AI-generated submissions? We found that significant numbers of our applicants last year used AI to generate work and in some cases CVs, and when candidates got to an assessment centre the quality of writing was much lower than seen in recent years
Need to be careful when comparing prices from one country to another. Industry talks about list prices (what they'd like to be paid) vs negotiated prices. I recall the US list price of some of the HCV drugs was 3x the negotiated price in EU, which in turn was higher than average price paid in US.
This was my favourite science road graffiti. From the 2020 Il Lombardia.
That is a sweet version of what maybe my favourite song of theirs.
Hitting the nail on the head...
open.substack.com/pub/rorycell... Purging a leading Parkinson’s researcher, spreading vaccine scares - how Trump and RFK have demolished the US reputation as the global health superpower in just a few weeks
Trump and Kennedy - bad for our health
Rory’s Always On Newsletter is a reader-supported publication.
open.substack.com
We also noticed that the standard of writing in our assessment centre exercises left a lot to be desired.
This thread reflects my experience with our early talent recruitment this year. Many candidates using the same AI-generated phrases in their applications, and we saw some reading AI-drafted responses in real time in online interviews. AI is making recruitment much more challenging.
I want to share some observations from a recent recruitment process for a PhD position that may be interesting for other future candidates 🧵
Lisa is correct here.

Won't be holding my breath waiting for them to speak up though.
Noticeably silent amid the upheaval at HHS? Big pharma. Every new drug has NIH somewhere in its DNA--and NIH funding supports the training of their workforce. Now they're finding out FDA isn't safe, either. Wrote about how keeping quiet isn't working My latest @opinion.bloomberg.com (gift link):
Big Pharma Needs to Get Off the Sidelines
The industry can’t continue to sit idly by while Robert F. Kennedy Jr. guts the nation’s public health agencies.
www.bloomberg.com
"Bluesky - AlphaMotorHomes - DeCeuster - Corendon" 😉